Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes

Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes

US Patent 6133242 · Granted Oct 17, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceut2025
Modulators of alpha-1 antitrypsin2025
Crystalline forms of CFTR modulators2025
Inhibitors of APOL1 and methods of using same2024
Modulators of alpha-1 antitrypsin2024
Crystalline forms of CFTR modulators2024
Modulators of alpha-1 antitrypsin2023
Inhibitors of APOL1 and methods of using same2023
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceut2022
Melanocortin-1 receptor-specific peptides for cytokine storm and inflammation th2022
Methods of reducing the risk of experiencing a cardiovascular (CV) event or a ce2021
Processes for preparing ATR inhibitors2020